FDA — authorised 20 March 2018
- Application: BLA761067
- Marketing authorisation holder: SUN PHARMA GLOBAL
- Local brand name: ILUMYA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 ILUMYA in United States
FDA authorised ILUMYA on 20 March 2018
Marketing authorisation
ILUMYA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is ILUMYA approved in United States?
Yes. FDA authorised it on 20 March 2018.
Who is the marketing authorisation holder for ILUMYA in United States?
SUN PHARMA GLOBAL holds the US marketing authorisation.